{"entity":{"type":"insider","cik":"0001737428","url":"/insider/0001737428","json_url":"/insider/0001737428.json","name":"Patel Chintu","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2020-03-10","last":"2021-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Patel Chintu","source":"filing","n_filings":3,"first_seen":"2020-03-10","last_seen":"2021-12-17"}],"transactions":[{"id":4795552,"accession":"0001209191-21-070258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-070258","line_url":"/filing/0001209191-21-070258#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":212500.0,"total_display":"212,500.00","total_whole":"212,500","shares_owned_after":512566.0,"shares_owned_after_display":"512,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-17","scope":"insider"},{"id":4795547,"accession":"0001209191-21-070258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-070258","line_url":"/filing/0001209191-21-070258#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":413000.0,"total_display":"413,000.00","total_whole":"413,000","shares_owned_after":462566.0,"shares_owned_after_display":"462,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":2455600,"accession":"0000899243-20-007990","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-007990","line_url":"/filing/0000899243-20-007990#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO and Director), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO and Director","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":309000.0,"total_display":"309,000.00","total_whole":"309,000","shares_owned_after":356107.0,"shares_owned_after_display":"356,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-11","scope":"insider"},{"id":2857054,"accession":"0000899243-20-007819","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-007819","line_url":"/filing/0000899243-20-007819#line-3","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO and Director), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO and Director","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58765.0,"shares_display":"58,765","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":233297.05,"total_display":"233,297.05","total_whole":"233,297","shares_owned_after":256107.0,"shares_owned_after_display":"256,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-10","scope":"insider"},{"id":2857049,"accession":"0000899243-20-007819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-007819","line_url":"/filing/0000899243-20-007819#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO and Director), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO and Director","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":156539.0,"shares_display":"156,539","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":607371.32,"total_display":"607,371.32","total_whole":"607,371","shares_owned_after":197342.0,"shares_owned_after_display":"197,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-10","scope":"insider"},{"id":2857041,"accession":"0000899243-20-007819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-007819","line_url":"/filing/0000899243-20-007819#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001737428","owner_name":"Patel Chintu","owner_display_name":"Patel Chintu","owner_url":"/insider/0001737428","role":"Director, Officer (Co-CEO and Director), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO and Director","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34696.0,"shares_display":"34,696","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":134273.52,"total_display":"134,273.52","total_whole":"134,274","shares_owned_after":40803.0,"shares_owned_after_display":"40,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001723128","name":"Amneal Pharmaceuticals, Inc.","url":"/issuer/0001723128","role":"Director, Officer (Co-CEO), Ten percent owner","n_filings":3,"first_seen":"2020-03-10","last_seen":"2021-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001737428","retrieved_at":"2026-08-27T02:36:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}